Iterion Therapeutics
Clinical-stage biotechnology company developing novel therapeutics targeting the Wnt pathway for liver cancer and colorectal cancer, spun out from University of Utah and Huntsman Cancer Institute.
Location
Houston, Texas, USA
Founded
2019
Investors
1
Categories
biotech, oncology, wnt-pathway, liver-cancer
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Portal Innovations | US | biotech-focused | - | 13 |